Jane Wright-mitchell - Net Worth and Insider Trading

Jane Wright-mitchell Net Worth

The estimated net worth of Jane Wright-mitchell is at least $184,797 dollars as of 2026-09-11. Jane Wright-mitchell is the General Counsel of Vaxcyte Inc and owns about 3,125 shares of Vaxcyte Inc (PCVX) stock worth over $184,797. Details can be seen in Jane Wright-mitchell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jane Wright-mitchell has not made any transactions after 2021-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Jane Wright-mitchell

Are these stocks worth buying? — GuruFocus analysis for each holding

- GF

PCVX Vaxcyte Inc

100% of holdings · $184K

Jane Wright-mitchell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jane Wright-mitchell owns 3 companies in total, including Vaxcyte Inc (PCVX) , Talphera Inc (TLPH) , and Vera Therapeutics Inc (VERA) .

Click here to see the complete history of Jane Wright-mitchell’s form 4 insider trades.

Insider Ownership Summary of Jane Wright-mitchell

Ticker	Company	Transaction Date	Type of Owner
PCVX	Vaxcyte Inc	2021-08-16	General Counsel
TLPH	Talphera Inc	2014-07-23	Chief Legal Officer
VERA	Vera Therapeutics Inc	2026-03-23	Chief Legal Officer

Jane Wright-mitchell Latest Holdings Summary

Jane Wright-mitchell currently owns a total of 1 stock. Jane Wright-mitchell owns 3,125 shares of Vaxcyte Inc (PCVX) as of August 16, 2021, with a value of $184,797.

Latest Holdings of Jane Wright-mitchell

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PCVX	Vaxcyte Inc	2021-08-16	3,125	59.14	184,797

Holding Weightings of Jane Wright-mitchell

Jane Wright-mitchell Form 4 Trading Tracker

According to the SEC Form 4 filings, Jane Wright-mitchell has made a total of 0 transactions in Vaxcyte Inc (PCVX) over the past 5 years. The most-recent trade in Vaxcyte Inc is the sale of 2,500 shares on August 16, 2021, which brought Jane Wright-mitchell around $65,000.

Insider Trading History of Jane Wright-mitchell

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jane Wright-mitchell Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks

See GF Score, valuation, financials, and warning signs for every stock Jane Wright-mitchell owns.

- PCVX

View PCVX Analysis

Jane Wright-mitchell Ownership Network

Ownership Network List of Jane Wright-mitchell

No Data

Ownership Network Relation of Jane Wright-mitchell

Jane Wright-mitchell Owned Company Details

What does Vaxcyte Inc do?

Who are the key executives at Vaxcyte Inc?

Jane Wright-mitchell is the General Counsel of Vaxcyte Inc. Other key executives at Vaxcyte Inc include Chief Operating Officer Jim Wassil , SVP Cml Mfg & Supply Chain Harpreet S. Dhaliwal , and CFO & CBO Andrew Guggenhime .

Vaxcyte Inc (PCVX) Insider Trades Summary

Over the past 18 months, Jane Wright-mitchell made no insider transaction in Vaxcyte Inc (PCVX). Other recent insider transactions involving Vaxcyte Inc (PCVX) include a net sale of 24,837 shares made by Jim Wassil , a net sale of 19,015 shares made by Elvia Cowan , and a net sale of 66,896 shares made by Grant Pickering .

In summary, during the past 3 months, insiders sold 124,588 shares of Vaxcyte Inc (PCVX) in total and bought 0 shares, with a net sale of 124,588 shares. During the past 18 months, 167,491 shares of Vaxcyte Inc (PCVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 167,491 shares.

Vaxcyte Inc (PCVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vaxcyte Inc Insider Transactions

No Available Data

What does Talphera Inc do?

Who are the key executives at Talphera Inc?

Jane Wright-mitchell is the Chief Legal Officer of Talphera Inc. Other key executives at Talphera Inc include director & Chief Executive Officer Vincent J. Angotti , Chief Medical Officer Shakil Aslam , and Chief Engineering Officer Badri N Dasu .

Talphera Inc (TLPH) Insider Trades Summary

Over the past 18 months, Jane Wright-mitchell made no insider transaction in Talphera Inc (TLPH). Other recent insider transactions involving Talphera Inc (TLPH) include a net purchase of 531,984 shares made by Vincent J. Angotti , a net purchase of 45,000 shares made by Raffi Asadorian , and a net purchase of 35,000 shares made by Badri N Dasu .

In summary, during the past 3 months, insiders sold 0 shares of Talphera Inc (TLPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Talphera Inc (TLPH) were sold and 646,984 shares were bought by its insiders, resulting in a net purchase of 646,984 shares.

Talphera Inc (TLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Talphera Inc Insider Transactions

No Available Data

What does Vera Therapeutics Inc do?

Who are the key executives at Vera Therapeutics Inc?

Jane Wright-mitchell is the Chief Legal Officer of Vera Therapeutics Inc. Other key executives at Vera Therapeutics Inc include director & President and CEO Marshall Fordyce , Chief Regulatory Officer Nancy Lee Boman , and Chief Commercial Officer Laurence Matthew Skelton .

Vera Therapeutics Inc (VERA) Insider Trades Summary

Over the past 18 months, Jane Wright-mitchell made no insider transaction in Vera Therapeutics Inc (VERA). Other recent insider transactions involving Vera Therapeutics Inc (VERA) include a net sale of 141,626 shares made by Marshall Fordyce , a net sale of 32,187 shares made by William D. Turner , and a net purchase of 255,882 shares made by Patrick G Enright .

In summary, during the past 3 months, insiders sold 83,250 shares of Vera Therapeutics Inc (VERA) in total and bought 0 shares, with a net sale of 83,250 shares. During the past 18 months, 207,055 shares of Vera Therapeutics Inc (VERA) were sold and 255,882 shares were bought by its insiders, resulting in a net purchase of 48,827 shares.

Vera Therapeutics Inc (VERA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vera Therapeutics Inc Insider Transactions

No Available Data

Jane Wright-mitchell Mailing Address

Above is the net worth, insider trading, and ownership report for Jane Wright-mitchell. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jane Wright-mitchell's mailing address is: Brisbane Ca 94005.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.